BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16900783)

  • 1. Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2006; 20(4):519-25. PubMed ID: 16900783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study.
    Bodey B; Bodey V; Siegel SE
    In Vivo; 2008; 22(1):83-7. PubMed ID: 18396787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2002; 16(6):583-8. PubMed ID: 12494904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1999; 19(4B):3293-314. PubMed ID: 10652626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
    Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1759-68. PubMed ID: 10928105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
    Körner M; Reubi JC
    J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
    Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of proline-directed protein kinase, (p34cdc2/p58cyclin A), a novel cell proliferation marker in childhood brain tumors.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2002; 16(6):589-94. PubMed ID: 12494905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.
    Lapointe M; Lanthier J; Moumdjian R; Régina A; Desrosiers RR
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):93-103. PubMed ID: 15857672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
    Gunal A; Onguru O; Safali M; Beyzadeoglu M
    Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1769-80. PubMed ID: 10928106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.
    Ellert-Miklaszewska A; Grajkowska W; Gabrusiewicz K; Kaminska B; Konarska L
    Brain Res; 2007 Mar; 1137(1):161-9. PubMed ID: 17239827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypical analysis and immunobiology of childhood brain tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1999; 19(4B):2973-92. PubMed ID: 10652582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of VEGF expression and related neo-angiogenesis in childhood high-grade gliomas: implications for anti-angiogenic anti-neoplastic therapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2006; 20(4):511-8. PubMed ID: 16900782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma.
    Gilbertson RJ; Hill DA; Hernan R; Kocak M; Geyer R; Olson J; Gajjar A; Rush L; Hamilton RL; Finkelstein SD; Pollack IF
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3620-4. PubMed ID: 14506149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival.
    Warth A; Simon P; Capper D; Goeppert B; Tabatabai G; Herzog H; Dietz K; Stubenvoll F; Ajaaj R; Becker R; Weller M; Meyermann R; Wolburg H; Mittelbronn M
    J Neurosci Res; 2007 May; 85(6):1336-46. PubMed ID: 17335082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.